key: cord-0881816-2fuvr6du
authors: Carbone, Ilma Floriana; Conforti, Alessandro; Farina, Antonio; Alviggi, Carlo
title: A practical approach for the management of obstetric and infertile women during the Phase Two of the Novel Coronavirus Disease 2019 (COVID ‐19) Pandemic
date: 2020-06-08
journal: Eur J Obstet Gynecol Reprod Biol
DOI: 10.1016/j.ejogrb.2020.06.006
sha: ce6a38d08ffcf02bbd2cc405e47dd4989ba46cf0
doc_id: 881816
cord_uid: 2fuvr6du

nan

Since December 2019, the outbreak of the novel coronavirus disease 2019 (COVID-19) has rapidly spread from China worldwide until to be declared a pandemic. To date, worldwide, almost 5 million confirmed cases of COVID-19 have been reported.

It is urgent to address the impact of this pandemic on the obstetric and reproductive medicine, seeking for reorganization strategies of daily practice (1-2).

Although professional bodies and experts have provided specific guidance (2), based on current limited evidences, data on obstetric, neonatal and reproductive outcomes are still partial (3) . In many countries after national lockdown, a Phase 2 started relaxing restrictions. To manage this phase, we recommend adopting rigorous preventive measures. Global lockdown has significantly impacted on new births, especially on those obtained with assisted reproductive technology (ART).

 Outpatient management. Avoid unnecessary inpatient monitoring.

 Routine antenatal care should be organized by a triaging procedure. For suspected patients, visits should be deferred; if it cannot be delayed, they should be performed in a dedicated outpatient clinical setting, as for symptomatic or positive patients.

 Telemedicine is encouraged to minimize number of visits.

 Testing for COVID-19 before any obstetric invasive procedure patients is recommended.  Breastfeeding and rooming in may be allowed

Given that ART babies represent about 0.3% of the total live birth rate every year and the increasing population decline registered in industrialized countries, a worldwide restart of fertility treatment is necessary. Recently, an international panel of expert identified which patients should be prioritized for fertility care (5). Advanced age women (i.e. age ≥ 35 years) with low prognosis to ART, tend to lose their fertility potential faster than other infertile women. Other subgroups of women who should be prioritized are those who need urgent fertility preservation, including women affected by systemic autoimmune disorders who presented a restricted timeframe during which fertility preservation is possible. Progressively, once the risk of COVID-19 infection is decreasing, other ART treatment could restart following local regulations. The key principle in ART treatment during Phase II is that COVID-19 symptoms should be excluded before and during ART treatment in patients, staff and anyone attending ART centers.

In conclusion, management of obstetric and infertile women should be carefully performed in countries who are progressively relaxing restrictive measures using strict triaging. Outcome record and data sharing are encouraged to improve our knowledge and address the further phases of COVID-19 pandemic.

The authors report no conflict of interest 

Management of a delivery suite during the COVID-19 epidemic

The novel coronavirus (2019-nCoV) in pregnancy: What we need to know

COVID-19 during pregnancy: Potential risk for neurodevelopmental disorders in neonates?

How to reduce the potential risk of vertical transmission of SARS-CoV-2 during vaginal delivery?

COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.